Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Attending Doctor

Oncology · China · 2025-06-11

Processing Time
169 days
Decision Date
2025-06-11
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his work in personalized oncology by developing tailored treatment regimens based on molecular diagnostics and tumor genomics. His research focuses on refining patient stratification to enable more effective and less toxic cancer therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the national importance of accelerating precision oncology and improving treatment consistency for U.S. patients.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned through a history of NIH-affiliated funding, 27 publications, and 542 citations.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's unique contributions to molecular diagnostics and patient stratification provide a benefit that outweighs the requirement of a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 27 peer-reviewed papers and 542 citations, with several papers ranking in the top 5% of the field. Evidence included 9 peer review roles for high-impact journals, funding from NIH-affiliated foundations, and strong expert support confirming the national importance of his biomarker framework.

Request for Evidence (RFE)

Successfully Addressed

The RFE issued on February 11, 2025, was addressed by providing concrete evidence of extraordinary ability via citation benchmarks, funding history, and expert endorsements.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorOn Balance, Beneficial to Waive Job Offer

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Government Alignment

Similar Cases

Clinical Researcher

Healthcare · Vietnam

WeGreened EB-2 (NIW) rfe approved
139 days 2025-04-24
The petitioner proposes to advance personalized oncology by integrating multi-omics analysis for biomarker discovery and population pharmacokinetic modeling to optimize cancer therapy. His work focuses on implementing model-informed precision dosing strategies and translating these innovations into real-world clinical settings to improve patient-centered therapeutic interventions.
View Case

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Assistant Professor

Healthcare · Lebanon

WeGreened EB-2 (NIW) approved
New York 283 days 2025-02-14
The petitioner proposes to continue his clinical research in precision oncology and immune profiling, focusing on the use of biomarkers to improve the diagnosis and treatment of complex cancers such as renal cell carcinoma and multiple myeloma. His work involves the development and validation of novel imaging and staining techniques to better understand immune microenvironments and treatment responses.
View Case

Project Manager

Biotechnology · India

WeGreened EB-2 (NIW) approved
Alabama 26 days 2024-12-02
The petitioner plans to develop precision biomarker oncology tests for biopsy samples to advance clinical cancer trials and drug development. Her work focuses on elucidating unique characteristics of cancer cells to establish therapeutic targets for precision medicine.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 169 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist